株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

Vichem Chemie Research Ltd.:製品パイプライン分析

Vichem Chemie Research Ltd - Product Pipeline Review - 2016

発行 Global Markets Direct 商品コード 293923
出版日 ページ情報 英文 32 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.98円で換算しております。
Back to Top
Vichem Chemie Research Ltd.:製品パイプライン分析 Vichem Chemie Research Ltd - Product Pipeline Review - 2016
出版日: 2016年12月30日 ページ情報: 英文 32 Pages
概要

Vichem Chemie Research Ltd. は、キナーゼ阻害薬を使った信号伝達療法の研究開発に力を入れているバイオテクノロジーの研究型企業です。キナーゼ阻害剤ライブラリー、インビトロバイオロジー、ADMETの最適化、創薬標的タンパク質の釣り上げなど、様々なサービスを提供しています。

当レポートではVichem Chemie Research Ltd.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Vichem Chemie Research Ltd.の基本情報

  • Vichem Chemie Research Ltd.の概要
  • 主要情報
  • 企業情報

Vichem Chemie Research Ltd.:R&Dの概要

  • 主な治療範囲

Vichem Chemie Research Ltd.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

Vichem Chemie Research Ltd.:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Vichem Chemie Research Ltd.:薬剤プロファイル

  • 中枢神経系・自己免疫疾患向け小分子
  • HIV-1型感染症向け CDK9 阻害小分子
  • VID-45110
  • BBH-7
  • BTP-15
  • 未公表の症状向け VEGFR2 拮抗小分子
  • 非小細胞肺癌・肺腺癌向け EGFR 阻害小分
  • 急性骨髄白血病向け FLT3 阻害小分子
  • 癌・細菌感染症向け PLK1 阻害小分子
  • 未公表の症状向け ROCK2 阻害小分子
  • 慢性心臓疾患向け小分子
  • 大腸菌感染症向け小分子
  • 多発性骨髄腫向け小分子
  • 腫瘍学向け HGFR/EGFR 拮抗小分子
  • 腫瘍学向け Pan FGFR 拮抗小分子
  • 腫瘍学向け PDGFR-beta 拮抗小分子
  • 腫瘍学向けオーロラAキナーゼ阻害小分子
  • 腫瘍学向けオーロラBキナーゼ 阻害小分子
  • 腫瘍学向け阻害小分子 CDK4
  • VCC-405567
  • VCC-668662

Vichem Chemie Research Ltd.:パイプライン分析

  • 標的別
  • 分子タイプ別
  • 作用機序別

Vichem Chemie Research Ltd.:休止中のプロジェクト

Vichem Chemie Research Ltd.:本社と子会社の所在地

付録

図表一覧

目次
Product Code: GMDHC08198CDB

Summary:

Global Markets Direct's, 'Vichem Chemie Research Ltd - Product Pipeline Review - 2016', provides an overview of the Vichem Chemie Research Ltd's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Vichem Chemie Research Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the pipeline therapeutic landscape of Vichem Chemie Research Ltd
  • The report provides overview of Vichem Chemie Research Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Vichem Chemie Research Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Vichem Chemie Research Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy:

  • Evaluate Vichem Chemie Research Ltd's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Vichem Chemie Research Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Vichem Chemie Research Ltd's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Vichem Chemie Research Ltd Snapshot
    • Vichem Chemie Research Ltd Overview
    • Key Facts
  • Vichem Chemie Research Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Vichem Chemie Research Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd - Pipeline Products Glance
    • Vichem Chemie Research Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd - Drug Profiles
    • BBH-7 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • BTP-15 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule for Oncology - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule for Tuberculosis - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small molecule to Inhibit FLT3 for Acute Myeloid Leukemia - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules for Melanoma - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit CDK9 for HIV-1 Infection - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit IRS-1 for Type 2 Diabetes - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit Pan FGFR for Oncology - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • VCC-234718 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Vichem Chemie Research Ltd - Pipeline Analysis
    • Vichem Chemie Research Ltd - Pipeline Products by Target
    • Vichem Chemie Research Ltd - Pipeline Products by Molecule Type
    • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action
  • Vichem Chemie Research Ltd - Dormant Projects
  • Vichem Chemie Research Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Vichem Chemie Research Ltd, Key Facts
  • Vichem Chemie Research Ltd - Pipeline by Indication, 2016
  • Vichem Chemie Research Ltd - Pipeline by Stage of Development, 2016
  • Vichem Chemie Research Ltd - Monotherapy Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Partnered Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Partnered Products/ Combination Treatment Modalities, 2016
  • Vichem Chemie Research Ltd - Preclinical, 2016
  • Vichem Chemie Research Ltd - Discovery, 2016
  • Vichem Chemie Research Ltd - Pipeline by Target, 2016
  • Vichem Chemie Research Ltd - Pipeline by Molecule Type, 2016
  • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action, 2016
  • Vichem Chemie Research Ltd - Dormant Developmental Projects,2016

List of Figures

  • Vichem Chemie Research Ltd - Pipeline by Top 10 Indication, 2016
  • Vichem Chemie Research Ltd - Pipeline by Stage of Development, 2016
  • Vichem Chemie Research Ltd - Monotherapy Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Pipeline by Target, 2016
  • Vichem Chemie Research Ltd - Pipeline by Molecule Type, 2016
  • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action, 2016
Back to Top